Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,900,000 | 9,311,000 | 4,368,300 | 5,336,100 | 5,914,700 |
| Marketable Securities | 1,301,000 | 293,000 | 1,118,100 | 2,894,700 | 2,798,300 |
| Receivables | 7,344,000 | 6,603,000 | 2,907,700 | 3,636,200 | 3,314,800 |
| Inventories | 5,868,000 | 8,048,000 | 2,091,000 | 1,881,000 | 1,769,400 |
| Income taxes - deferred | 3,651,000 | 4,177,000 | 8,627,500 | N/A | N/A |
| TOTAL | $29,064,000 | $28,432,000 | $19,112,600 | $15,045,400 | $15,230,200 |
| Non-Current Assets | |||||
| PPE Net | 17,082,000 | 18,279,000 | 11,999,600 | 12,346,000 | 13,194,100 |
| Investments And Advances | 2,175,000 | 432,000 | 6,491,300 | 7,159,200 | 7,788,200 |
| Intangibles | 51,834,000 | 59,795,000 | 1,964,100 | 2,168,000 | 2,375,500 |
| Other Non-Current Assets | 5,626,000 | 5,376,000 | 7,628,100 | 11,632,100 | 5,981,800 |
| TOTAL | $76,717,000 | $83,882,000 | $28,083,100 | $33,305,300 | $29,339,600 |
| Total Assets | $105,781,000 | $112,314,000 | $47,195,700 | $48,350,700 | $44,569,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,308,000 | 2,244,000 | 617,600 | 624,500 | 7,149,900 |
| Accrued Expenses | 8,514,000 | 9,455,000 | 9,174,100 | 8,534,900 | N/A |
| Other current liabilities | N/A | 207,000 | N/A | N/A | N/A |
| TOTAL | $15,641,000 | $15,641,000 | $14,318,700 | $12,258,200 | $12,722,700 |
| Non-Current Liabilities | |||||
| Long Term Debt | 15,482,000 | 16,095,000 | 3,943,300 | 3,915,800 | 5,551,000 |
| Other Non-Current Liabilities | -121,000 | -123,000 | -124,000 | 2,285,300 | 2,406,100 |
| TOTAL | $33,335,000 | $35,188,000 | $11,709,900 | $17,907,800 | $14,287,400 |
| Total Liabilities | $48,976,000 | $50,829,000 | $26,028,600 | $30,166,000 | $27,010,100 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,083,081 | 3,115,317 | 2,107,712 | 2,165,290 | 2,166,483 |
| Common Shares | 1,788,000 | 1,781,000 | 29,800 | 29,800 | 29,800 |
| Retained earnings | 37,536,000 | 41,405,000 | 43,698,800 | 39,140,800 | 39,095,100 |
| Other shareholders' equity | -787,000 | -340,000 | -144,600 | -825,800 | -1,164,700 |
| TOTAL | $56,805,000 | $61,485,000 | $21,167,100 | $18,184,700 | $17,559,700 |
| Total Liabilities And Equity | $105,781,000 | $112,314,000 | $47,195,700 | $48,350,700 | $44,569,800 |